Ticker | $ Bought |
---|---|
johnson & johnson | 11,280,400 |
elanco animal health inc | 3,353,340 |
ptc therapeutics inc | 2,945,380 |
tandem diabetes care inc | 2,378,150 |
Ticker | % Inc. |
---|---|
amgen inc | 187 |
centene corp del | 78.95 |
pfizer inc | 40.85 |
zimmer biomet holdings inc | 29.92 |
legend biotech corp | 25.11 |
humana inc | 16.67 |
biomarin pharmaceutical inc | 14.18 |
ionis pharmaceuticals inc | 11.86 |
Ticker | % Reduced |
---|---|
baxter intl inc | -58.79 |
ge healthcare technologies i | -53.14 |
bristol-myers squibb co | -39.18 |
elevance health inc | -34.25 |
gilead sciences inc | -31.7 |
cvs health corp | -28.15 |
cardinal health inc | -24.85 |
incyte corp | -23.78 |
Ticker | $ Sold |
---|---|
alkermes plc | -2,799,000 |
agios pharmaceuticals inc | -3,017,150 |
universal hlth svcs inc | -4,036,760 |
SECTOR GAMMA AS has about 93.4% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 93.4 |
Others | 6.6 |
SECTOR GAMMA AS has about 82.4% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
LARGE-CAP | 78.5 |
MID-CAP | 11 |
UNALLOCATED | 6.6 |
MEGA-CAP | 3.9 |
About 80.2% of the stocks held by SECTOR GAMMA AS either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
S&P 500 | 78.4 |
Others | 19.8 |
RUSSELL 2000 | 1.8 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
SECTOR GAMMA AS has 29 stocks in it's portfolio. About 61.2% of the portfolio is in top 10 stocks. CVS proved to be the most loss making stock for the portfolio. BMY was the most profitable stock for SECTOR GAMMA AS last quarter.
Last Reported on: 11 Feb, 2025Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
PFE | pfizer inc | 10.53 | 1,155,000 | 30,642,200 | added | 40.85 | ||
Historical Trend of PFIZER INC Position Held By SECTOR GAMMA ASWhat % of Portfolio is PFE?:Number of PFE shares held:Change in No. of Shares Held: | ||||||||
MDT | medtronic plc | 8.79 | 320,000 | 25,561,600 | reduced | -4.45 | ||
BMY | bristol-myers squibb co | 7.12 | 366,166 | 20,710,300 | reduced | -39.18 | ||
GILD | gilead sciences inc | 6.27 | 197,500 | 18,243,100 | reduced | -31.7 | ||
BDX | becton dickinson & co | 5.93 | 76,000 | 17,242,100 | reduced | -1.66 | ||
ZBH | zimmer biomet holdings inc | 5.00 | 137,714 | 14,546,700 | added | 29.92 | ||
BMRN | biomarin pharmaceutical inc | 4.91 | 217,348 | 14,286,300 | added | 14.18 | ||
INCY | incyte corp | 4.69 | 197,400 | 13,634,400 | reduced | -23.78 | ||
AMGN | amgen inc | 4.12 | 46,000 | 11,989,400 | added | 187 | ||
JNJ | johnson & johnson | 3.88 | 78,000 | 11,280,400 | new | |||
CAH | cardinal health inc | 3.58 | 88,000 | 10,407,800 | reduced | -24.85 | ||
CNC | centene corp del | 3.54 | 170,000 | 10,298,600 | added | 78.95 | ||
CVS | cvs health corp | 3.35 | 217,000 | 9,741,130 | reduced | -28.15 | ||
BRKR | bruker corp | 3.20 | 158,970 | 9,318,820 | unchanged | 0.00 | ||
qiagen nv | 3.12 | 203,993 | 9,083,810 | reduced | -8.57 | |||
IONS | ionis pharmaceuticals inc | 2.84 | 235,842 | 8,245,040 | added | 11.86 | ||
EW | edwards lifesciences corp | 2.52 | 99,000 | 7,328,970 | reduced | -6.74 | ||
ELV | elevance health inc | 2.19 | 17,279 | 6,374,220 | reduced | -34.25 | ||
BIO | bio rad labs inc | 1.90 | 16,829 | 5,528,500 | unchanged | 0.00 | ||
BAX | baxter intl inc | 1.59 | 158,650 | 4,626,230 | reduced | -58.79 | ||